Renin-Angiotensin System Inhibitors, Type 2 Diabetes and Fibrosis Progression: An Observational Study in Patients with Nonalcoholic Fatty Liver Disease

BACKGROUND: The clinical determinants of fibrosis progression in nonalcoholic fatty liver disease (NAFLD) are still under definition. AIM: To assess the clinical determinants of fibrosis progression rate (FPR) in NAFLD patients with baseline and follow-up histological evaluation, with a special focu...

Descripción completa

Detalles Bibliográficos
Autores principales: Pelusi, Serena, Petta, Salvatore, Rosso, Chiara, Borroni, Vittorio, Fracanzani, Anna Ludovica, Dongiovanni, Paola, Craxi, Antonio, Bugianesi, Elisabetta, Fargion, Silvia, Valenti, Luca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5029872/
https://www.ncbi.nlm.nih.gov/pubmed/27649410
http://dx.doi.org/10.1371/journal.pone.0163069

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5029872/
https://www.ncbi.nlm.nih.gov/pubmed/27649410
http://dx.doi.org/10.1371/journal.pone.0163069

Ejemplares similares